ProShare Advisors
ASMB icon

ProShare Advisors’s Assembly Biosciences ASMB Stock Holding History

ProShare Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,123
Closed -$62K – 2372
2021
Q1 		$62K Buy
1,123
+131
+13% +$8.68K ﹤0.01% 2212
2020
Q4 		$72K Buy
+992
New +$116K ﹤0.01% 2021
2020
Q3 		– Sell
-783
Closed -$219K – 1642
2020
Q2 		$219K Buy
+783
New +$183K ﹤0.01% 1408
2013
Q3 		– Sell
-213
Closed -$31K – 2524
2013
Q2 		$31K Buy
+213
New +$33.4K ﹤0.01% 2373

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

ProShare Advisors's ASMB Position: Q2 2021 in Review

ProShare Advisors sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 1,123 shares — an estimated $62K sold.

ProShare Advisors first reported a position in ASMB in Q2 2013 and held it in 4 quarters. The position peaked at $219K in Q2 2020. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • ProShare Advisors reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • ProShare Advisors sold 1,123 Assembly Biosciences shares in Q2 2021, an estimated $62K.
  • ProShare Advisors first reported a position in Assembly Biosciences in Q2 2013 and held it in 4 quarters.
  • ProShare Advisors's Assembly Biosciences position peaked at $219K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.